SKF-83959
SKF-83959 is a drug that acts as a Dopamine receptor agonist specifically at D1/D5 receptor subtype. It has neuroprotective effects and has been proposed as a treatment for Parkinson's disease.
Pharmacology[edit | edit source]
SKF-83959 is a Dopamine receptor agonist, but unlike most D1-like receptor agonists, it does not produce cAMP but instead stimulates Phosphatidylinositol (PI) hydrolysis, which makes it a useful research tool. It has been shown to have neuroprotective effects and is being researched for potential therapeutic roles in conditions such as Parkinson's disease and Huntington's disease.
Clinical significance[edit | edit source]
Research has suggested that SKF-83959 may have potential therapeutic benefits in the treatment of Parkinson's disease. It has been shown to improve motor function and reduce L-DOPA-induced dyskinesia in animal models of the disease. Further research is needed to determine its efficacy and safety in humans.
See also[edit | edit source]
References[edit | edit source]
SKF-83959 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD